January 2020

Coalition Advocates for Biosimilar Uptake to Help Lower Employers’ Drug Cost Burden

2020-01-21T14:05:14-05:00January 21st, 2020|Drug Cost News, EmployersRx, News|

Rising drug costs in the United States are a pressing concern not only for patients who need to receive those drugs, but also for employers. The Employers’ Prescription for Affordable Drugs (EmployersRx) is a coalition that aims to tackle this problem by working with policy makers and stakeholders to encourage and facilitate more transparency, competition,

EmployersRx on “Not So Different”: Employers Advocate for Lower Drug Costs Through Biosimilars

2020-01-15T12:00:25-05:00January 15th, 2020|Drug Cost News, EmployersRx, News|

With pharmaceutical spending at record levels, employers are looking for solutions and are hopeful that biosimilars can play a role in controlling costs. On this episode of "Not So Different," Elizabeth Mitchell and Lauren Vela (from EmployersRx founding member Pacific Business Group on Health) spoke with Allison Inserro of The Center for Biosimilars about the

November 2019

New Analysis Finds Large Drugmakers Could Lose $1 Trillion in Sales and Still Be the Most Profitable Industry

2019-11-15T12:34:05-05:00November 15th, 2019|Drug Cost News, News|

A new analysis of publicly reported financial data by researchers at West Health Policy Center and Johns Hopkins Bloomberg School of Public Health finds that large, brand-name drug manufacturers would still be the most profitable industry sector even with $1 trillion in lower sales, all while maintaining current research investments. Read about the report's findings >

October 2019

September 2019

August 2019